Skip to Content

BNVA 150 (Boniva 150 mg)

Generic Name: ibandronate

Pill with imprint BNVA 150 is White, Elliptical / Oval and has been identified as Boniva 150 mg. It is supplied by Roche Laboratories.

Boniva is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for BNVA 150

Boniva

Generic Name:
ibandronate
Imprint:
BNVA 150
Strength:
150 mg
Color:
White
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Roche Laboratories
Inactive Ingredients:
lactose monohydrate
povidone k25
microcrystalline cellulose
crospovidone
stearic acid
silicon dioxide
water
hypromelloses
titanium dioxide
magnesium silicate
polyethylene glycol 6000
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54868-5322 Physicians Total Care Inc. (repackager)
35356-0423 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide